Latest Apoptosis Stories
- DIPG cells respond to TRXE-009 in vitro SYDNEY and SAN DIEGO, May 8, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Limited (ASX:NRT; NASDAQ:NVGN), in conjunction
Unique delivery vehicle to be developed across p53 mutated solid tumors by delivering wild type p21 NEW YORK and ZUG, Switzerland, April 15, 2015 /PRNewswire/ -- SELLAS Life Sciences
Ubiquitin system produces a protein that greatly restricts the development of cancerous tumors NEW YORK, April 10, 2015 /PRNewswire-USNewswire/ -- A new study by researchers at the
Cancer research has truly gone to the dogs as scientists at the University of Illinois have announced the start of phase I trials for a drug showed good results in the treatment of spontaneously occurring cancers in pet dogs.
Georgia State University has signed a license agreement with Cisen Pharmaceutical Co.
A new protein-based treatment could help treat acute lymphoblastic leukemia (ALL) patients whose cancer cells have developed resistance to contemporary chemotherapy, according to new research published online Monday in the Journal of Clinical Investigation.
UC Davis researchers have uncovered a complex interaction between the proteins Rbm38 and p53 that governs tumor suppression and aging Sacramento, Calif.
A University of Colorado Cancer Center study being presented at the San Antonio Breast Cancer Symposium shows that triple negative breast cancer cells process tryptophan to promote survival while
New Assay Critical to the Study of the Human Immune Responses and Cancers. State College, PA (PRWEB) October 17, 2014 INDIGO Biosciences, a leading provider
- A hairdresser.